4.79% -0.0357

Durect Corp (DRRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt DRRX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Durect Corp Stock (DRRX) Company Profile

Healthcare (1152)

(408) 777-1417

10240 BUBB ROAD, CUPERTINO, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

DRRX's Discussions on Twitter

Vergleichen Sie DRRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DRRX Durect Corp	0.71	22.60M	8.59M	-17.07M	-21.90M	-0.61
ZTS Zoetis Inc	145.49	67.28B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.12	45.61B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.82	45.01B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	13.28	15.64B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	283.04	12.77B	2.76B	1.11B	898.10M	22.77

Durect Corp Stock (DRRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-10-30	Eingeleitet	Chardan Capital Markets	Buy
2020-10-12	Eingeleitet	ROTH Capital	Buy
2020-07-31	Eingeleitet	Oppenheimer	Outperform
2020-01-31	Eingeleitet	B. Riley FBR	Buy
2019-11-18	Fortgesetzt	Cantor Fitzgerald	Overweight
2019-09-06	Eingeleitet	Cantor Fitzgerald	Overweight
2018-03-06	Hochstufung	H.C. Wainwright	Neutral → Buy
2017-10-20	Herabstufung	H.C. Wainwright	Buy → Neutral
2017-10-20	Bestätigt	Laidlaw	Buy
2017-10-20	Herabstufung	Stifel	Buy → Hold
2017-07-12	Hochstufung	Stifel	Hold → Buy
2017-02-28	Fortgesetzt	H.C. Wainwright	Buy
2016-04-25	Eingeleitet	Rodman & Renshaw	Buy
2015-05-01	Bestätigt	Cantor Fitzgerald	Buy
2015-05-01	Bestätigt	Stifel	Buy
2013-03-25	Eingeleitet	Stifel	Buy
2012-11-01	Herabstufung	C.K. Cooper	Buy → Hold
2012-08-17	Eingeleitet	C.K. Cooper	Buy
2009-06-23	Eingeleitet	Caris & Company	Buy
2009-03-26	Eingeleitet	Wedbush Morgan	Hold

Alle ansehen

Durect Corp Aktie (DRRX) Neueste Nachrichten

Finanzdaten der Durect Corp-Aktie (DRRX)

Durect Corp (DRRX)

Durect Corp Stock (DRRX) Company Profile

Vergleichen Sie DRRX mit anderen Aktien

Durect Corp Stock (DRRX) Upgrades & Downgrades

Durect Corp Aktie (DRRX) Neueste Nachrichten

StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX) - Defense World

Durect Corp stock hits 52-week low at $0.7 amid market challenges - Investing.com Canada

DURECT (NASDAQ:DRRX) Coverage Initiated at StockNews.com - Defense World

DURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call Transcript - MSN

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation - Yahoo Finance

DURECT Corporation’s Earnings Call Highlights Cost Cuts and Breakthrough Potential - TipRanks

Durect Corp Q4 2024 Earnings: EPS of $0.25 Surpasses Estimates, Revenue Falls Short at $0.5 Million - GuruFocus

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges - Yahoo Finance

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic F - GuruFocus.com

Durect: Q4 Earnings Snapshot - MySA

Durect reports Q4 cont ops EPS (6c), consensus (2c) - TipRanks

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Earnings call transcript: Durect’s Q4 2024 revenue drops as focus shifts to key drug - Investing.com India

DURECT Corp reports results for the quarter ended December 31Earnings Summary - TradingView

DURECT Transforms Business: $17.5M Asset Sale, NEJM Evidence Validates Key Drug Program - Stock Titan

Earnings Scheduled For March 26, 2025 - Benzinga

What To Expect From Durect Corp (DRRX) Q4 2024 Earnings - GuruFocus

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 - GuruFocus.com

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - Quantisnow

DURECT (DRRX) to Release Quarterly Earnings on Wednesday - Defense World

StockNews.com Begins Coverage on DURECT (NASDAQ:DRRX) - Defense World

DURECT Corporation (NASDAQ:DRRX) Is Expected To Breakeven In The Near Future - Simply Wall St

Wnt efforts condensing at Dewpoint, Surrozen, more - BioWorld Online

Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial - Healio

DURECT (NASDAQ:DRRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

The R&D Dept.: Local patent roundup for 2.26.25 - RichmondBizSense

DURECT (NASDAQ:DRRX) Research Coverage Started at StockNews.com - Defense World

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Yahoo Finance

Exclusive Healthcare Conference Alert: DURECT CEO Reveals Latest Developments - Stock Titan

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence - Stockhouse Publishing

DURECT (NASDAQ:DRRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Durect (DRRX) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Geode Capital Management LLC Has $429,000 Holdings in DURECT Co. (NASDAQ:DRRX) - Defense World

DURECT faces Nasdaq delisting over share price - Investing.com

New Strong Buy Stocks for January 9th - Yahoo Finance

Reviewing Acerus Pharmaceuticals (OTCMKTS:TRLPF) and DURECT (NASDAQ:DRRX) - Defense World

Microbial Products Market Size to Hit USD 351.42 Bn by 2034 - Precedence Research

Durect (DRRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

DURECT Corp expected to post a loss of 17 cents a shareEarnings Preview - XM

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

DURECT Corp sells ALZET product line to Lafayette - TradingPedia

Durect announces sale of Alzet line of osmotic pumps to LIC for $17.5M - TipRanks

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PR Newswire

Finanzdaten der Durect Corp-Aktie (DRRX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie DRRX